This event has ended. Create your own event → Check it out
This event has ended. Create your own
View analytic
Thursday, September 21 • 1:10pm - 1:40pm
SDDN Programming: Roundtable Discussion
Feedback form is now closed.
This year the SDDN / SLAS 2017 meeting has the theme "Case Studies in Drug Discovery and Development", and it will showcase several success stories, from academia, biotech, and pharma; opportunities, challenges, solutions and lessons learned will be highlighted. 

The morning's speakers will participate in a moderated roundtable discussion moderated by Ion Arocena, ASEBIO. 

This programme is graciously sponsored by Promega

avatar for Ion Arocena

Ion Arocena

General Manager, ASEBIO, the Spanish Bioindustry Association.
Ion Arocena is currently the General Manager of ASEBIO, the Spanish Bioindustry Association. Ion has worked for long as an investment management executive, with deep knowledge of the Life Sciences market. He studied Biotechnology in Madrid and completed his studies with an executive MBA at EOI Business School. He worked at the Technology Transfer Office of the Universidad... Read More →

avatar for José Antonio Enríquez

José Antonio Enríquez

Dr. José Antonio Enríquez, has a wide experience in biogenesis and pathology of mtDNA. He obtained his PhD studying the expression of mtDNA in the departamento de Bioquímica (Universidad de Zaragoza) and supported by a D.G.A. fellowship. In 1992, started his post-doctoral training in CALTECH, under... Read More →
avatar for Julio Martin

Julio Martin

Head of Kinetoplastid Biology, Director, GSK
I am currently working at the Kinetoplastid Discovery Performance Unit of GSK R&D at Tres Cantos (Spain). Our remit is to discover and develop new chemical entities for the treatment of human diseases caused by kinetoplastid parasites such as Leishmania and Trypanosoma. Our strategy is based on open innovation and collaborative... Read More →
avatar for Raúl Martín-Ruiz

Raúl Martín-Ruiz

Ysios Capital
Raúl Martín-Ruiz is a Principal in Ysios Capital, a leading independent Spanish venture capital firm that provides private equity financing to human healthcare and life sciences companies. Prior to joining Ysios in 2008 he developed his career in Laboratorios Almirall, initially... Read More →
avatar for Arsenio Nueda

Arsenio Nueda

Head, Cell Systems, Almirall, S.A.
I have 18 years experience in the Pharmaceutical Industry and a previous 10 year track record in Academia. I obtained my PhD in 1995 under the direction of Angel Corbí (Hospital de La Princesa, Madrid) working in the characterization of human leukocyte integrin gene promoters. My... Read More →
avatar for Amelia Martín Uranga

Amelia Martín Uranga

Amelia is PHD  in Law, with a thesis on legal protection of biotechnological innovations. She joined FARMAINDUSTRIA in 2006 to manage the Spanish Technological Platform for Innovative Medicines, as Innovative Medicines Initiative mirror. She also is in charge of the coordination... Read More →
avatar for Miguel Vega

Miguel Vega

Miguel has a broad background in engineering and management, with specific training and expertise in molecular and cell biology, chemical and biochemical synthesis, industrial processing as well project design and implementation. For the last 20 years he has been involved in proj... Read More →
avatar for María Jesús Vicent

María Jesús Vicent

Team Leader (Polymer Therapeutics Laboratory-Scree, Centro de Investigación Príncipe Felipe
Dr. María J. Vicent received her Ph.D. degree in 2001 in chemistry on solid supports from University Jaume I after several scientific stays in Prof. Fréchet’s lab. at University California, Berkeley (USA). Then, she moved to more biomedically oriented research, initially with a Spanish company Instituto Biomar SA., and subsequently at the Centre for Polymer Therapeutics with Prof. R. Duncan after the award of a Marie Curie Postdoctoral Fellowship in 2002. In 2004... Read More →

Thursday September 21, 2017 1:10pm - 1:40pm
Rosales I Courtyard by Marriot Madrid Princesa Hotel